From 2006-2008, he was Chief Medical Officer and Vice President of Clinical Affairs at Napo Pharmaceuticals, where he co-authored the two-stage pivotal adaptive trial design leading to approval of ...

The countdown begins to the highly anticipated Adaptive Designs in Clinical Trials conference in April this year. With the growing popularity in use and acceptance of adaptive designs in clinical ...

Clinical trial design is a key aspect of the successful conduct of clinical trials. It involves deciding parameters such as the number of patients, the length of the trial, the comparator arm (in ...

PhaseV has formed a strategic collaboration with Alimentiv to support the design and execution of adaptive clinical trials targeting gastrointestinal (GI) conditions. This collaboration ...

But while platform trials have the potential to be more effective and less expensive than traditional trials, challenges ...

The Clinical Trial Success Prediction capability ... and CROs are leveraging PhaseV's platform to rapidly design and execute adaptive, Bayesian and fixed clinical trials, analyze data to uncover ...

PhaseV, a leader in AI/ML-driven clinical development, today announced its participation in several upcoming biotech and data ...

In this video interview, Thierry Escudier, portfolio lead, Pistoia Alliance, discusses the alliance’s latest step in ...

This has implications for clinical practice and trial design. We evaluated the duration of first-, second-, and third-line chemotherapy as a surrogate for duration of treatment response.